Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — dried blood spot hormone testing

Breast cancer rates have risen from 1 in 30 to 1 in 8 women over the past 30 years — yet the focus remains on treatment rather than prevention. Drawing on 35 years of clinical experience and infrared thermography, this article makes the case that environmental toxins, xenoestrogens, hormone imbalance and lifestyle factors may account for 91–93% of breast cancer risk. Prevention, not just awareness, is the real cure.

Menopause affects approximately 40–50 million women in the US alone — yet it remains widely misunderstood. This article answers the five essential questions: who is affected, what menopause actually is, when it typically begins, where in the body it originates, and why hormone balance is the key to navigating this natural transition with health and vitality.

When sex hormone test results show both oestradiol (E2) and progesterone (Pg) within normal ranges, yet symptoms persist, the Pg/E2 ratio provides a critical additional layer of clinical insight. A low ratio points to oestrogen dominance; a high ratio to progesterone dominance — each requiring a different therapeutic response. This article explains how the ratio is calculated, when it is clinically relevant, and how a real-world case illustrates its practical value.

Millions of people struggle with weight gain, fatigue and low mood despite being told their thyroid test results are “normal.” The problem is that a standard TSH test alone cannot identify the full range of factors that suppress thyroid function — from oestrogen dominance and elevated cortisol to iodine deficiency, selenium deficiency, heavy metal toxicity and xenoestrogen burden. This article explains what those hidden saboteurs are and how targeted testing can help identify them.

Infertility affects 8–12% of couples worldwide, yet many of the hormonal causes — from undiagnosed Hashimoto’s and PCOS to luteal phase defects and thyroid dysfunction — go undetected by standard testing. A comprehensive first-line fertility hormone panel covering sex hormones, thyroid, adrenal markers and ovarian reserve can identify what is really getting in the way of conception, and dramatically improve the odds of success with fertility treatments.